Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,285,888
-$85,094 QoQ
Shares Held
10,178
+3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#972
of 2,266 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Portfolio Design Labs, LLC holds $28,086,107 across 10 Drug Manufacturers - General names. GILD ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,672 | $11,600,887 | |
| 2 | JNJ |
Johnson & Johnson
|
26,190 | $6,651,474 | |
| 3 | ABBV |
AbbVie Inc.
|
11,344 | $2,854,604 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,354 | $2,101,489 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
10,178 | $1,285,888 | |
| 6 | PFE |
Pfizer Inc
|
50,289 | $1,210,959 | |
| 7 | AMGN |
Amgen Inc
|
3,317 | $1,201,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,294 | $708,380 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,285,888 | 10,178 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,370,982 | 9,837 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,519,398 | 12,379 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,348,428 | 12,148 | Shares | Sole | 2025-11-12 | |
| 2023-12-31 | $296,496 | 3,660 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||